Evofem investor relations
WebAug 4, 2024 · Evofem Biosciences, Inc. (NASDAQ: EVFM) Q2 2024 Earnings Conference Call August 4, 2024 11:00 AM ET Company Participants • Amy Raskopf – Head of IR • … WebMay 4, 2024 · Evofem Biosciences, Inc. (EVFM) Q1 2024 Results - Earnings Call May 04, 2024 4:30pm ET Company Participants Amy Raskopf - Vice President-Investor …
Evofem investor relations
Did you know?
WebMay 4, 2024 · Evofem Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Update Published: May 04, 2024 Double digit growth in net revenues … WebAug 5, 2024 · Evofem Biosciences, Inc. ( OTC:EVFM) Q2 2024 Earnings Conference Call August 4, 2024 5:00 PM ET Company Participants Amy Raskopf - Vice President-Investor Relations Saundra Pelletier - Chief...
WebSep 16, 2024 · The healthcare investor that provided $25 million to Evofem under the April 2024 Securities Purchase and Security Agreement agreed to accept future interest payments as payment-in-kind instead of cash. ... SVP, Investor Relations Evofem Biosciences, Inc. [email protected] (917) 673-5775. WebAug 11, 2024 · August 10, 2024, 8:23 PM · 1 min read. -- Conference Call Scheduled for 5:00 p.m. ET --. SAN DIEGO, Aug. 10, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., …
WebAug 4, 2024 · Stifel Downgrades Evofem Biosciences to Hold From Buy, Adjusts Price Target to $0.50 Fr.. MT. 2024. HC Wainwright Adjusts Price Target on Evofem Biosciences to $4 From $2, Reiterates Buy .. MT. 2024. Morgan Stanley Adjusts Price Target for Evofem Biosciences to $0.75 From $2, Maintains .. MT. More recommendations. WebJan 18, 2024 · Immediately following the completion of the merger, an existing investor of Evofem, Invesco Asset Management Limited, as agent for and on behalf of its discretionary managed clients, purchased shares of common stock in the merged company for an aggregate purchase price of $20 million. ... Investor Relations 858-550-1900 ext. 167 …
WebEvofem Biosciences Inc (EVFM) Stock Price Today, News, Quotes, FAQs and Fundamentals Advertisement 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. EVFM Evofem Biosciences Inc 21,210 Watch $0.0208 $0.0011 (5.02%) Today $0.00 0.00 (0.00%) After Hours Market Cap $2.86M Volume (M) 1.78M …
WebMay 4, 2024 · Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and … cnpj aec juazeiroWebApr 12, 2024 · Investor Contact Amy Raskopf Evofem Biosciences, Inc. [email protected] (917) 673-5775 . View original content to download multimedia: ... Investor Relations: [email protected] 070-571 65 88 Övrig annonsering: [email protected] 070-968 50 91 ... cnpj ace sao joao da boa vistaWebEvofem Biosciences has raised a total of $470.8M in funding over 16 rounds. Their latest funding was raised on May 20, 2024 from a Post-IPO Equity round. Evofem Biosciences is registered under the ticker NASDAQ:EVFM . Evofem Biosciences is funded by 12 investors. Keystone Capital and Adjuvant Capital are the most recent investors. cnpj aec granja julietaWebMay 20, 2024 · SAN DIEGO, May 20, 2024 /PRNewswire/ -- Evofem Biosciences, Inc. (Nasdaq: EVFM) (Evofem) today announced the pricing of its previously announced underwritten public offering of 22,665,000... cnpj ajeWebAug 4, 2024 · SAN DIEGO, Aug. 4, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) ("Evofem" or the "Company"), today reported financial results for the … tasnim ka kitchencnpj advogadoWebNov 15, 2024 · Evofem's ability to obtain the necessary regulatory approvals for its product candidates and the timing of such approvals, and, Any other risk factors detailed in Evofem's filings from time to time with the U.S. Securities and Exchange Commission including, without limitation, the 10-K filed on March 12, 2024, 8-K filed on June 2, 2024 … cnpj ahgora